Clinical Trial Update: Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects [Phase 2, Phase 3]

View source ↗

Summary

Safety and tolerability results for Acoziborole in gambiense human African trypanosomiasis seropositive subjects from a Phase 2/3 trial have been completed, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human African Trypanosomiasis

Drugs mentioned

• Acoziborole (acoziborole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-03-20